Laboratory Interpretation: Iron Deficiency in a Patient on Testosterone Therapy
This patient has iron deficiency anemia, evidenced by a ferritin of 19 μg/L (well below the normal range of 20-200 μg/L for men), and requires immediate iron supplementation and evaluation for the underlying cause of iron loss. 1
Primary Findings
Iron Deficiency (Ferritin 19 μg/L)
- The ferritin level of 19 μg/L is diagnostic of iron deficiency, falling below the normal range for men (20-200 μg/L) established by the American Association for the Study of Liver Diseases 1
- Functional assessment indicates that iron deficiency anemia begins when ferritin reaches 10 μg/L, and this patient is approaching that critical threshold 2
- This low ferritin is inconsistent with iron overload or hemochromatosis, which would show ferritin levels of 150-1000+ μg/L 1
Elevated Hematocrit (51.1%)
- The hematocrit of 51.1% is elevated above the normal range and represents secondary erythrocytosis, likely induced by testosterone therapy 3
- Testosterone therapy increases hematocrit by suppressing hepcidin (by 28%), increasing erythropoietin (by 21%), and upregulating ferroportin and transferrin receptor expression 3
- This creates a paradoxical situation: testosterone-driven erythrocytosis is depleting iron stores as the bone marrow consumes available iron for red blood cell production 3
Elevated Vitamin B12 (1370 pg/mL)
- This elevation is not clinically concerning and does not require intervention
- Elevated B12 can occur with supplementation, liver disease, or malignancy, but in isolation without other concerning features, it is typically benign 4
UBC 352 (Unclear Units/Context)
- If this refers to urinary ferritin or urinary blood cells, elevated levels could indicate hemolysis or renal tubular iron deposition 5
- However, without clear context on what "UBC" represents, this value cannot be definitively interpreted
- If urinary ferritin, levels >170 μg/L suggest chronic hemolysis, which could contribute to iron depletion 5
Clinical Implications and Management
Immediate Actions Required
- Initiate oral iron supplementation (ferrous sulfate 325 mg daily or equivalent) to replenish iron stores 1
- Measure transferrin saturation to confirm iron deficiency and rule out other causes of low ferritin 6, 7
- Evaluate for sources of blood loss: gastrointestinal bleeding (especially in men), hematuria, or occult bleeding 1
- Consider checking complete blood count to assess for microcytic anemia (low MCV, low MCH) which would confirm iron deficiency anemia 2
Testosterone Therapy Considerations
- The testosterone therapy is exacerbating iron depletion by driving erythropoiesis without adequate iron stores 3
- Consider temporarily reducing testosterone dose or extending dosing intervals until iron stores are repleted 3
- Monitor hematocrit closely, as levels >54% increase risk of thrombotic events
- Iron supplementation is essential to continue testosterone therapy safely 3
Monitoring Plan
- Recheck ferritin and transferrin saturation in 8-12 weeks after starting iron supplementation 7
- Target ferritin level should be >50 μg/L to support ongoing erythropoiesis 2
- Monitor hematocrit every 3 months while on testosterone therapy 3
- If ferritin fails to rise despite supplementation, investigate for ongoing blood loss or malabsorption 1
Critical Pitfalls to Avoid
- Do not assume elevated hematocrit indicates adequate iron stores - this patient demonstrates that testosterone-induced erythrocytosis can coexist with severe iron deficiency 3
- Do not continue testosterone at current doses without addressing iron deficiency - this will worsen iron depletion and potentially cause symptomatic anemia 3
- Do not perform HFE genetic testing - the low ferritin excludes hemochromatosis, and such testing would be inappropriate and misleading 1, 6
- Avoid vitamin C supplements >500 mg/day once iron overload is excluded, though this is not relevant in this iron-deficient patient 7